MindBio Therapeutics Corp.
MBIO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -247.20K | -30.70K | -168.70K | 50.50K | -26.10K |
| Total Depreciation and Amortization | 57.80K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.00K | -67.70K | 170.30K | 46.60K | -86.70K |
| Change in Net Operating Assets | 38.00K | 44.50K | -17.90K | -2.70K | 27.40K |
| Cash from Operations | -91.40K | -53.90K | -16.30K | 94.30K | -85.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -8.00K | -12.60K | -- | -- |
| Issuance of Common Stock | 165.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 107.50K | -5.40K | -8.30K | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -45.60K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.20K | -59.20K | -70.30K | 94.30K | -85.40K |
